Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jilin Kangfu Pharmaceutical is a pharmaceutical company based in Changchun, Jilin Province, China, specializing in the development and manufacturing of a wide range of medicinal products. The company's portfolio encompasses both Traditional Chinese Medicine (TCM) and modern chemical pharmaceuticals, delivered in various dosage forms such as tablets, capsules, and granules. Its primary therapeutic focus areas include cardiovascular diseases, respiratory conditions, and infectious diseases. Jilin Kangfu operates state-of-the-art production facilities that adhere to national Good Manufacturing Practice (GMP) standards. As a regional leader in the Northeast China pharmaceutical sector, the company emphasizes quality control and the modernization of traditional therapies. It serves a broad domestic market, providing essential medications and health supplements to the Chinese healthcare system.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jilin Kangfu Pharmaceutical.